JP2018021037A5 - - Google Patents

Download PDF

Info

Publication number
JP2018021037A5
JP2018021037A5 JP2017148823A JP2017148823A JP2018021037A5 JP 2018021037 A5 JP2018021037 A5 JP 2018021037A5 JP 2017148823 A JP2017148823 A JP 2017148823A JP 2017148823 A JP2017148823 A JP 2017148823A JP 2018021037 A5 JP2018021037 A5 JP 2018021037A5
Authority
JP
Japan
Prior art keywords
recombinant fsh
pharmaceutical composition
cell line
sialylation
sialyltransferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017148823A
Other languages
English (en)
Japanese (ja)
Other versions
JP6762916B2 (ja
JP2018021037A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018021037A publication Critical patent/JP2018021037A/ja
Publication of JP2018021037A5 publication Critical patent/JP2018021037A5/ja
Priority to JP2019194476A priority Critical patent/JP7316905B2/ja
Application granted granted Critical
Publication of JP6762916B2 publication Critical patent/JP6762916B2/ja
Priority to JP2021175403A priority patent/JP2022031652A/ja
Priority to JP2023215339A priority patent/JP2024038000A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017148823A 2008-04-16 2017-08-01 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh Active JP6762916B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2019194476A JP7316905B2 (ja) 2008-04-16 2019-10-25 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh
JP2021175403A JP2022031652A (ja) 2008-04-16 2021-10-27 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh
JP2023215339A JP2024038000A (ja) 2008-04-16 2023-12-21 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4542408P 2008-04-16 2008-04-16
US61/045,424 2008-04-16
EP08251528 2008-04-25
EP08251528.9 2008-04-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016198588A Division JP6486310B2 (ja) 2008-04-16 2016-10-07 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019194476A Division JP7316905B2 (ja) 2008-04-16 2019-10-25 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh

Publications (3)

Publication Number Publication Date
JP2018021037A JP2018021037A (ja) 2018-02-08
JP2018021037A5 true JP2018021037A5 (cg-RX-API-DMAC7.html) 2018-11-08
JP6762916B2 JP6762916B2 (ja) 2020-09-30

Family

ID=39717519

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2011504527A Pending JP2011519359A (ja) 2008-04-16 2009-04-16 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh
JP2014262056A Pending JP2015120696A (ja) 2008-04-16 2014-12-25 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh
JP2016198588A Active JP6486310B2 (ja) 2008-04-16 2016-10-07 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh
JP2017148823A Active JP6762916B2 (ja) 2008-04-16 2017-08-01 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh
JP2019194476A Active JP7316905B2 (ja) 2008-04-16 2019-10-25 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh
JP2021175403A Pending JP2022031652A (ja) 2008-04-16 2021-10-27 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh
JP2023215339A Pending JP2024038000A (ja) 2008-04-16 2023-12-21 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2011504527A Pending JP2011519359A (ja) 2008-04-16 2009-04-16 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh
JP2014262056A Pending JP2015120696A (ja) 2008-04-16 2014-12-25 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh
JP2016198588A Active JP6486310B2 (ja) 2008-04-16 2016-10-07 アルファ2,3−およびアルファ2,6−シアリル化を含む組換えfsh

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019194476A Active JP7316905B2 (ja) 2008-04-16 2019-10-25 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh
JP2021175403A Pending JP2022031652A (ja) 2008-04-16 2021-10-27 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh
JP2023215339A Pending JP2024038000A (ja) 2008-04-16 2023-12-21 アルファ2,3-およびアルファ2,6-シアリル化を含む組換えfsh

Country Status (29)

Country Link
US (6) US8951967B2 (cg-RX-API-DMAC7.html)
EP (7) EP3098234B1 (cg-RX-API-DMAC7.html)
JP (7) JP2011519359A (cg-RX-API-DMAC7.html)
KR (5) KR102108377B1 (cg-RX-API-DMAC7.html)
CN (3) CN105906702A (cg-RX-API-DMAC7.html)
AR (1) AR071479A1 (cg-RX-API-DMAC7.html)
AU (5) AU2009237479B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910461B8 (cg-RX-API-DMAC7.html)
CA (1) CA2725257A1 (cg-RX-API-DMAC7.html)
CY (1) CY1115413T1 (cg-RX-API-DMAC7.html)
DK (6) DK3144318T3 (cg-RX-API-DMAC7.html)
ES (5) ES2610277T3 (cg-RX-API-DMAC7.html)
FI (4) FI3098234T3 (cg-RX-API-DMAC7.html)
FR (3) FR17C1020I2 (cg-RX-API-DMAC7.html)
HR (5) HRP20241187T1 (cg-RX-API-DMAC7.html)
HU (9) HUE068565T2 (cg-RX-API-DMAC7.html)
IL (2) IL208538A (cg-RX-API-DMAC7.html)
LT (8) LT3045471T (cg-RX-API-DMAC7.html)
MX (3) MX2010011343A (cg-RX-API-DMAC7.html)
NO (4) NO2017025I1 (cg-RX-API-DMAC7.html)
NZ (1) NZ588381A (cg-RX-API-DMAC7.html)
PL (6) PL3144318T3 (cg-RX-API-DMAC7.html)
PT (6) PT3098234T (cg-RX-API-DMAC7.html)
RU (3) RU2537268C2 (cg-RX-API-DMAC7.html)
SA (1) SA109300228B1 (cg-RX-API-DMAC7.html)
SI (6) SI4015527T1 (cg-RX-API-DMAC7.html)
TW (1) TWI488640B (cg-RX-API-DMAC7.html)
WO (1) WO2009127826A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201007373B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
HRP20150968T4 (hr) 2010-09-29 2023-11-10 Ferring B.V. Pripravak za uporabu za liječenje neplodnosti
KR101898302B1 (ko) 2010-10-15 2018-09-13 제이씨알 파마 가부시키가이샤 당사슬의 비환원 말단이 만노오스 잔기인 당 단백질의 제조 방법
CA2831486A1 (en) * 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
AR090095A1 (es) 2011-06-06 2014-10-22 Ferring Bv Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
AU2012340501A1 (en) * 2011-12-19 2013-07-11 Grifols, S.A. Compositions, methods, and kits for preparing sialylated recombinant proteins
WO2013161958A1 (ja) * 2012-04-27 2013-10-31 日本ケミカルリサーチ株式会社 新規な発現ベクター
EP2824176A1 (en) * 2013-07-11 2015-01-14 Siamed'xpress Methods for producing sialylated therapeutic proteins
JP6652334B2 (ja) 2014-05-31 2020-02-19 Jcrファーマ株式会社 ウリジンとn−アセチル−d−マンノサミンとを含有する培地
JP2018500934A (ja) * 2014-12-22 2018-01-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cmp依存性シアリダーゼ活性
ES2784625T3 (es) 2015-04-17 2020-09-29 Ferring Bv FSH para el tratamiento de la infertilidad
EP3313859B1 (en) 2015-06-26 2019-11-20 Ferring BV Methods of purification and/or viral inactivation
EP3205719A1 (en) * 2016-02-15 2017-08-16 CEVEC Pharmaceuticals GmbH Cell lines for producing recombinant glycoproteins with di-antennary n-glycans, methods using the same, and recombinant glycoproteins
GB201603280D0 (en) 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation
EP3382014A1 (en) * 2017-03-29 2018-10-03 CEVEC Pharmaceuticals GmbH Recombinant glycoproteins with reduced antennary fucosylation
EP3441471A1 (en) 2017-08-08 2019-02-13 CEVEC Pharmaceuticals GmbH Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines
AR112541A1 (es) 2017-09-01 2019-11-06 Ferring Bv Composición para estimulación ovárica controlada con hef recombinante
EP3787667B1 (en) 2018-04-30 2025-03-26 Ferring B.V. Composition for controlled ovarian stimulation
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US20220380785A1 (en) * 2019-11-01 2022-12-01 The University Of British Columbia Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
US20250241993A1 (en) 2022-04-01 2025-07-31 Ferring B.V. Mixed protocol for treatment of infertility
US20250333466A1 (en) 2022-05-26 2025-10-30 Ferring B.V. Compositions and methods for treatment of infertility in males
AU2023302100A1 (en) 2022-07-08 2025-01-02 Ferring B.V. Compositions and methods for intrauterine insemination (iui)
TW202504578A (zh) 2023-07-20 2025-02-01 荷蘭商輝凌責任有限公司 緩釋載藥微粒

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5541083A (en) 1989-10-24 1996-07-30 The Regents Of The University Of California Method for producing secretable glycosyltransferases and other golgi processing enzymes
EP1445322B2 (en) 1995-06-15 2012-06-06 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
JP3559652B2 (ja) * 1996-06-25 2004-09-02 グローリー工業株式会社 売上精算システムの管理装置
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
JP2001507215A (ja) 1997-01-16 2001-06-05 サイテル コーポレイション 組換え糖タンパク質のインビトロでの実用的なシアリル化
JPH1111665A (ja) 1997-06-28 1999-01-19 Shibuya Kogyo Co Ltd 無菌エア搬送コンベヤ装置
TWI235158B (en) * 1997-09-01 2005-07-01 Kirin Brewery Human thrombopoietin produced by human established cell lines, processes foe preparing the same, and pharmaceutical composition comprising the same
EP1176976B2 (en) 1999-05-07 2015-10-21 Laboratoires Serono SA Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women
JP2002011665A (ja) 2000-06-28 2002-01-15 Sintokogio Ltd ショットブラスト装置モニタシステム
IL140110A0 (en) 2000-12-05 2002-02-10 Applied Research Systems Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
EP1621549A3 (en) * 2001-10-22 2006-03-01 Applied Research Systems ARS Holding N.V. Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments
BR0213402A (pt) 2001-10-29 2004-10-13 Crucell Holland Bv Métodos para identificar uma célula de mamìfero capaz de produzir uma molécula proteinácea, para selecionar uma célula de mamìfero capaz de produzir uma molécula proteinácea, para se obter uma célula de mamìfero a partir de uma população heterogênea de células, e para produzir uma molécula proteinácea, composição farmaceuticamente aceitável, eritropoietina recombinantemente produzida, usos de uma célula de mamìfero, da eritropoietina recombinantemente produzida, e de uma composição de moléculas semelhantes à eritropoietina, preparação farmacêutica, método para o tratamento preventivo e/ou terapêutico de um distúrbio, composição de moléculas semelhates à eritropoietina, métodos para produzir, em uma célula de mamìfero, moléculas proteináceas, para produzir uma fração enriquecida em uma molécula proteinácea, e para fracionar uma mistura que contém moléculas proteináceas, fração, e, usos de uma fração ou composição, e de eritropoietina recombinantemente produzìvel em uma célula de mamìfero
CA2468957C (en) 2001-12-07 2011-07-12 Crucell Holland B.V. Methods of propagation of influenza virus in cell lines over expressing sialyl transferases
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US20080015142A1 (en) * 2003-12-03 2008-01-17 Defrees Shawn Glycopegylated Follicle Stimulating Hormone
DK1711834T3 (da) 2004-02-04 2010-11-29 Centre Nat Rech Scient Fremgangsmåde til screening af glycoform-specifikke antistoffer
CN1926242B (zh) 2004-02-13 2013-01-16 格莱克托普有限公司 高活性糖蛋白加工条件及其有效生产方法
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016575A1 (en) 2010-08-03 2012-02-09 King Saud University Stoma coat
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
HRP20150968T4 (hr) 2010-09-29 2023-11-10 Ferring B.V. Pripravak za uporabu za liječenje neplodnosti
CA2831486A1 (en) 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
AR090095A1 (es) 2011-06-06 2014-10-22 Ferring Bv Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
US20170035854A1 (en) 2014-04-18 2017-02-09 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone

Similar Documents

Publication Publication Date Title
JP2018021037A5 (cg-RX-API-DMAC7.html)
HRP20161520T1 (hr) Rekombinantni fsh uključujući alfa 2,3- i alfa 2,6-sialilaciju
JP2018127649A5 (cg-RX-API-DMAC7.html)
JP2016509011A5 (cg-RX-API-DMAC7.html)
JP2011078421A5 (cg-RX-API-DMAC7.html)
JP2017061668A5 (cg-RX-API-DMAC7.html)
JP1727982S (ja) 医療用ガウン
CN302589451S (zh) 玩具(床铃)
CN302537022S (zh) 护栏(06)
CN302537025S (zh) 护栏(02)
CN302532258S (zh) 护栏(05)
JP2019090111A5 (cg-RX-API-DMAC7.html)
CN302511420S (zh) 玩偶(心中有你1)
CN302509410S (zh) 瓶子(扁型)
CN302401178S (zh) 防松螺母
CN302484557S (zh) 浴霸(fthj7-6h)
CN302026889S (zh) 枕(u形圆柱双用枕)
CN302578252S (zh) 开关(椭圆形)
CN302587743S (zh) 吊坠(至纯金语-银杏-优雅2)
CN302587749S (zh) 吊坠(至纯金语-芙蓉-魅力)
CN302587751S (zh) 吊坠(至纯金语-银杏-韵味)
CN302587753S (zh) 吊坠(至纯金语-芙蓉-锦绣)
CN302587755S (zh) 项链(至纯金语-芙蓉-锦绣)
CN302187431S (zh) 包装瓶(酒瓶型)
CN302464434S (zh) 盘(正方布拉纹)